Patients increasingly come to visits with AI-generated ideas and online research, forcing doctors to balance information, ...

Administrative friction between hospitals and insurers remains a costly reality across US healthcare. According to the ...

Blood lead and mercury levels fall markedly among pregnant women in the UK since the early 1990s, and methylmercury accounts ...

In patients with heart failure, a lower TAPSE/PASP ratio is linked to higher rates of cardiovascular death or heart failure ...

During periods of extreme heat, several drug classes can make patients more vulnerable to dehydration, heat exhaustion, and ...

Your patient may not know it, for those with obesity, headaches can be a result. It is essential to acknowledge the established medical associations between these conditions and to engage in the ...

The weight-loss drug is approved to treat obstructive sleep apnea, but some types of patients seem to benefit the most.

Serum corticosteroid-binding globulin and total cortisol levels decrease rapidly and normalise within 4 weeks after the ...

Fathers’ adverse childhood experiences are linked to a higher likelihood of their children having behavior problems.

Dapagliflozin can reduce the risk for major adverse cardiovascular events in patients with T2D at a high risk for advanced liver fibrosis, according to a retrospective study.

Data from the first stage of a phase 3 study show significant reductions in proteinuria among patients treated with telitacicept.

The new framework removes the requirement for coverage with evidence determination (CED) for TAVR in patients with symptomatic severe aortic valve stenosis and extends coverage to asymptomatic aortic ...